Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 6723931, 16 pages
https://doi.org/10.1155/2017/6723931
Review Article

Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence

1Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
2Diabetes Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
3Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
4Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
5CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain
6Human Nutrition Unit, University Hospital of Sant Joan de Reus, Department of Biochemistry and Biotechnology, Faculty of Medicine and Health Sciences, IISPV, Rovira I Virgili University, Reus, Spain

Correspondence should be addressed to Marta Guasch-Ferré; ude.dravrah.hpsh@hcsaugm

Received 28 March 2017; Revised 19 June 2017; Accepted 3 July 2017; Published 13 August 2017

Academic Editor: Giuseppe Cirillo

Copyright © 2017 Marta Guasch-Ferré et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 7th edition, 2015.
  2. L. Chen, D. J. Magliano, and P. Z. Zimmet, “The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives,” Nature Reviews Endocrinology, vol. 8, pp. 228–236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. U.S. Department of Agriculture and U.S. Department of Helath and Human Services, Scientific Report of the 2015 Dietary Guidelines Advisory Committee, US Departmentof Health and Human Services, Washington (DC), 2015.
  4. A. Satija, S. N. Bhupathiraju, E. B. Rimm et al., “Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies,” PLoS Medicine, vol. 13, article e1002039, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Martínez-González, J. Salas-Salvadó, R. Estruch, D. D. Corella, M. Fitó, and E. Ros, “Benefits of the Mediterranean diet: insights from the PREDIMED study,” Progress in Cardiovascular Diseases, vol. 58, pp. 50–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Rangel-Huerta, B. Pastor-Villaescusa, C. Aguilera, and A. Gil, “A systematic review of the efficacy of bioactive compounds in cardiovascular disease: phenolic compounds,” Nutrients, vol. 7, pp. 5177–5216, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, pp. 270–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Pérez-Jiménez, V. Neveu, F. Vos, and A. Scalbert, “Identification of the 100 richest dietary sources of polyphenols: an application of the phenol-explorer database,” European Journal of Clinical Nutrition, vol. 64, Supplement 3, pp. S112–S120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Scalbert, C. Manach, C. Morand, C. Rémésy, and L. Jiménez, “Dietary polyphenols and the prevention of diseases,” Critical Reviews in Food Science and Nutrition, vol. 45, pp. 287–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Manach, A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez, “Polyphenols: food sources and bioavailability,” The American Journal of Clinical Nutrition, vol. 79, pp. 727–747, 2004. View at Google Scholar
  11. N. M. Wedick, A. Pan, A. Cassidy et al., “Dietary flavonoid intakes and risk of type 2 diabetes in US men and women,” The American Journal of Clinical Nutrition, vol. 95, pp. 925–933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Sun, N. M. Wedick, A. Pan et al., “Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women,” Diabetes Care, vol. 37, pp. 1287–1295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Tresserra-Rimbau, M. Guasch-Ferre, J. Salas-Salvado et al., “Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk,” The Journal of Nutrition, vol. 146, pp. 767–777, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. Shrime, S. R. Bauer, A. C. McDonald, N. H. Chowdhury, C. E. M. Coltart, and E. L. Ding, “Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies,” The Journal of Nutrition, vol. 141, pp. 1982–1988, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Hooper, C. Kay, A. Abdelhamid et al., “Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials,” The American Journal of Clinical Nutrition, vol. 95, pp. 740–751, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Curtis, M. Sampson, J. Potter, K. Dhatariya, P. A. Kroon, and A. Cassidy, “Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial,” Diabetes Care, vol. 35, pp. 226–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-X. Zheng, Y.-L. Xu, S.-H. Li, R. Hui, Y.-J. Wu, and X.-H. Huang, “Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials,” The American Journal of Clinical Nutrition, vol. 97, pp. 750–762, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Stull, K. C. Cash, W. D. Johnson, C. M. Champagne, and W. T. Cefalu, “Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women,” The Journal of Nutrition, vol. 140, pp. 1764–1768, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P.-W. Zhang, F.-X. Chen, D. Li, W.-H. Ling, and H.-H. Guo, “A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease,” Medicine (Baltimore), vol. 94, article e758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Basu, N. M. Betts, A. Nguyen, E. D. Newman, D. Fu, and T. J. Lyons, “Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids,” The Journal of Nutrition, vol. 144, pp. 830–837, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Z.-M. Liu, Y.-M. Chen, and S. C. Ho, “Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials,” The American Journal of Clinical Nutrition, vol. 93, pp. 1092–1101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Ricci, S. Cipriani, F. Chiaffarino, M. Malvezzi, and F. Parazzini, “Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women,” Menopause, vol. 17, pp. 1080–1086, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Rhee and A. Brunt, “Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design,” Nutrition Journal, vol. 10, p. 44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Lemay, S. Dodin, N. Kadri, H. Jacques, and J.-C. Forest, “Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women,” Obstetrics and Gynecology, vol. 100, pp. 495–504, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Pan, J. Sun, Y. Chen et al., “Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial,” PLoS One, vol. 2, article e1148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Pan, W. Demark-Wahnefried, X. Ye et al., “Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients,” The British Journal of Nutrition, vol. 101, p. 1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Cornish, P. D. Chilibeck, L. Paus-Jennsen et al., “A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults,” Applied Physiology, Nutrition, and Metabolism, vol. 34, pp. 89–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Javidi, H. Mozaffari-Khosravi, A. Nadjarzadeh, A. Dehghani, and M. H. Eftekhari, “The effect of flaxseed powder on insulin resistance indices and blood pressure in prediabetic individuals: a randomized controlled clinical trial,” Journal of Research in Medical Sciences, vol. 21, p. 70, 2016. View at Publisher · View at Google Scholar
  29. S. M. Made, J. Plat, and R. P. Mensink, “Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial,” PLoS One, vol. 10, article e0118393, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. E. Dijk, M. R. Olthof, J. C. Meeuse, E. Seebus, R. J. Heine, and R. M. Dam, “Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance,” Diabetes Care, vol. 32, pp. 1023–1025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Lecoultre, G. Carrel, L. Egli et al., “Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men,” The American Journal of Clinical Nutrition, vol. 99, pp. 268–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Kempf, C. Herder, I. Erlund et al., “Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial,” The American Journal of Clinical Nutrition, vol. 91, pp. 950–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. N. M. Wedick, A. M. Brennan, Q. Sun, F. B. Hu, C. S. Mantzoros, and R. M. Dam, “Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial,” Nutrition Journal, vol. 10, p. 93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. “COcoa Supplement and Multivitamin Outcomes Study (COSMOS),” https://www.clinicaltrials.gov/ct2/show/NCT02422745, 2016.
  35. Y.-J. Liu, J. Zhan, X.-L. Liu, Y. Wang, J. Ji, and Q.-Q. He, “Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies,” Clinical Nutrition, vol. 33, pp. 59–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Zamora-Ros, N. G. Forouhi, S. J. Sharp et al., “The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study,” Diabetes Care, vol. 36, pp. 3961–3970, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. P. F. Jacques, A. Cassidy, G. Rogers, J. J. Peterson, J. B. Meigs, and J. T. Dwyer, “Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes,” The Journal of Nutrition, vol. 143, pp. 1474–1480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Knekt, J. Kumpulainen, R. Järvinen et al., “Flavonoid intake and risk of chronic diseases,” The American Journal of Clinical Nutrition, vol. 76, pp. 560–568, 2002. View at Google Scholar
  39. Y. Song, J. E. Manson, J. E. Buring, H. D. Sesso, and S. Liu, “Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis,” Journal of the American College of Nutrition, vol. 24, pp. 376–384, 2005. View at Google Scholar
  40. M. K. Kataja-Tuomola, J. P. Kontto, S. Männistö, D. Albanes, and J. Virtamo, “Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers,” European Journal of Clinical Nutrition, vol. 65, pp. 590–597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Zamora-Ros, N. G. Forouhi, S. J. Sharp et al., “Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations,” The Journal of Nutrition, vol. 144, pp. 335–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ding, A. Pan, J. E. Manson et al., “Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts,” European Journal of Clinical Nutrition, vol. 70, pp. 1381–1387, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Bulló, R. Lamuela-Raventós, and J. Salas-Salvadó, “Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants,” Current Topics in Medicinal Chemistry, vol. 11, pp. 1797–1810, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Medina-Remón, R. Casas, A. Tressserra-Rimbau et al., “PREDIMED study investigators: polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial,” British Journal of Clinical Pharmacology, vol. 83, pp. 114–128, 2017. View at Publisher · View at Google Scholar
  45. R. Estruch, M. A. Martínez-González, D. Corella et al., “Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial,” Annals of Internal Medicine, vol. 145, pp. 1–11, 2006. View at Publisher · View at Google Scholar
  46. J. Salas-Salvadó, M. Bulló, R. Estruch et al., “Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial,” Annals of Internal Medicine, vol. 160, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  47. E. Ros, “Olive oil and CVD: accruing evidence of a protective effect,” The British Journal of Nutrition, vol. 108, pp. 1931–1933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Martín-Peláez, M. I. Covas, M. Fitó, A. Kušar, and I. Pravst, “Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims,” Molecular Nutrition & Food Research, vol. 57, pp. 760–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Bock, J. G. B. Derraik, C. M. Brennan et al., “Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial,” PLoS One, vol. 8, article e57622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Wainstein, T. Ganz, M. Boaz et al., “Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats,” Journal of Medicinal Food, vol. 15, pp. 605–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Silva, M. R. Bronze, M. E. Figueira et al., “Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study,” The American Journal of Clinical Nutrition, vol. 101, pp. 44–54, 2015. View at Google Scholar
  52. C. Santangelo, C. Filesi, R. Varì et al., “Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin,” Journal of Endocrinological Investigation, vol. 39, pp. 1295–1301, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Lasa, J. Miranda, M. Bulló et al., “Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes,” European Journal of Clinical Nutrition, vol. 68, pp. 767–772, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. M.-I. Covas, K. Nyyssönen, H. E. Poulsen et al., “The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial,” Annals of Internal Medicine, vol. 145, pp. 333–341, 2006. View at Publisher · View at Google Scholar
  55. V. Konstantinidou, O. Khymenets, M.-I. Covas et al., “Time course of changes in the expression of insulin sensitivity-related genes after an acute load of virgin olive oil,” Omics, vol. 13, pp. 431–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Casas-Agustench, P. Lopez-Uriarte, M. Bullo, E. Ros, J. J. Cabre-Vila, and J. Salas-Salvado, “Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 21, pp. 126–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Luo, Y. Zhang, Y. Ding et al., “Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis,” The American Journal of Clinical Nutrition, vol. 100, pp. 256–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. I. Kang, T. Buckner, N. F. Shay, L. Gu, and S. Chung, “Improvements in metabolic health with consumption of Ellagic acid and subsequent conversion into urolithins: evidence and mechanisms,” Advances in Nutrition: An International Review Journal, vol. 7, pp. 961–972, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Mora-Cubillos, S. Tulipani, M. Garcia-Aloy, M. Bulló, F. J. Tinahones, and C. Andres-Lacueva, “Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome,” Molecular Nutrition & Food Research, vol. 59, pp. 2480–2490, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. M. M. Marcadenti, M. Markoski, J. Garavaglia, A. Oliveira, and J. Olivaes, “Molecular properties of red wine compounds and cardiometabolic benefits,” Nutrition and Metabolic Insights, vol. 9, p. 51, 2016. View at Publisher · View at Google Scholar
  61. G. Chiva-Blanch, M. Urpi-Sarda, E. Ros et al., “Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial,” Clinical Nutrition, vol. 32, pp. 200–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Napoli, D. Cozzolino, V. Guardasole et al., “Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients,” Metabolism, vol. 54, pp. 306–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Castilla, R. Echarri, A. Dávalos et al., “Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects,” The American Journal of Clinical Nutrition, vol. 84, pp. 252–262, 2006. View at Google Scholar
  64. L. Cordain, C. L. Melby, A. E. Hamamoto et al., “Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women,” Metabolism, vol. 49, pp. 1473–1478, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. J. W. J. Beulens, R. M. Beers, R. P. Stolk, G. Schaafsma, and H. F. J. Hendriks, “The effect of moderate alcohol consumption on fat distribution and adipocytokines,” Obesity (Silver Spring), vol. 14, pp. 60–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Hokayem, E. Blond, H. Vidal et al., “Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients,” Diabetes Care, vol. 36, pp. 1454–1461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Timmers, E. Konings, L. Bilet et al., “Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans,” Cell Metabolism, vol. 14, pp. 612–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Gepner, R. Golan, I. Harman-Boehm et al., “Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial,” Annals of Internal Medicine, vol. 163, pp. 569–579, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Mamluk, M. G. O’Doherty, P. Orfanos et al., “Fruit and vegetable intake and risk of incident of type 2 diabetes: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES),” European Journal of Clinical Nutrition, vol. 71, pp. 83–91, 2017. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Kim, J. B. Keogh, and P. M. Clifton, “Polyphenols and glycemic control,” Nutrients, vol. 8, p. 17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Hanhineva, R. Törrönen, I. Bondia-Pons et al., “Impact of dietary polyphenols on carbohydrate metabolism,” International Journal of Molecular Sciences, vol. 11, pp. 1365–1402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. G. Berná, M. J. Oliveras-López, E. Jurado-Ruíz et al., “Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis,” Nutrients, vol. 6, pp. 5338–5369, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. P. V. A. Babu, D. Liu, and E. R. Gilbert, “Recent advances in understanding the anti-diabetic actions of dietary flavonoids,” The Journal of Nutritional Biochemistry, vol. 24, pp. 1777–1789, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. J. K. Lee, K. Kim, Y. Ahn, M. Yang, and J. E. Lee, “Habitual coffee intake, genetic polymorphisms, and type 2 diabetes,” European Journal of Endocrinology, vol. 172, pp. 595–601, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Palatini, E. Benetti, L. Mos et al., “Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients,” European Journal of Epidemiology, vol. 30, pp. 209–217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. InterAct Consortium, “Investigation of gene-diet interactions in the incretin system and risk of type 2 diabetes: the EPIC-InterAct study,” Diabetologia, vol. 59, pp. 2613–2621, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Corella, P. Carrasco, J. V. Sorli et al., “Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: a randomized controlled trial in a high-cardiovascular-risk population,” Diabetes Care, vol. 36, pp. 3803–3811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. Grant SFA, G. Thorleifsson, I. Reynisdottir et al., “Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes,” Nature Genetics, vol. 38, pp. 320–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Zhou, S.-Y. Park, J. Su et al., “TCF7L2 is a master regulator of insulin production and processing,” Human Molecular Genetics, vol. 23, pp. 6419–6431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. R. D. Beger, W. Dunn, M. A. Schmidt et al., “Metabolomics enables precision medicine: “a white paper, community perspective”,” Metabolomics, vol. 12, p. 149, 2016. View at Publisher · View at Google Scholar · View at Scopus
  81. Q. Sun, N. M. Wedick, S. S. Tworoger et al., “Urinary excretion of select dietary polyphenol metabolites is associated with a lower risk of type 2 diabetes in proximate but not remote follow-up in a prospective investigation in 2 cohorts of US women,” The Journal of Nutrition, vol. 145, pp. 1280–1288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Ding, A. A. Franke, B. A. Rosner et al., “Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women,” The British Journal of Nutrition, vol. 114, pp. 1694–1701, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Zhao, Y. Zhu, N. Hyun et al., “Novel metabolic markers for the risk of diabetes development in American Indians,” Diabetes Care, vol. 38, pp. 220–227, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. K.-P. Ko, C.-S. Kim, Y. Ahn et al., “Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study,” Diabetologia, vol. 58, pp. 726–735, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. X. Guo, A. Tresserra-Rimbau, R. Estruch et al., “Effects of polyphenol, measured by a biomarker of total polyphenols in urine, on cardiovascular risk factors after a long-term follow-up in the PREDIMED study,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2572606, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. A. H. Lee, L’. Tan, N. Hiramatsu et al., “Plasma concentrations of coffee polyphenols and plasma biomarkers of diabetes risk in healthy Japanese women,” Nutrition & Diabetes, vol. 6, article e212, 2016. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Eichholzer, A. Richard, H. L. Nicastro, E. A. Platz, J. Linseisen, and S. Rohrmann, “Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008,” Cancer Causes & Control, vol. 25, pp. 395–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Struja, A. Richard, J. Linseisen, M. Eichholzer, and S. Rohrmann, “The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES,” European Journal of Nutrition, vol. 53, pp. 1371–1381, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Xu, Q. Liu, Q. Zhang, A. Gu, and Z.-Y. Jiang, “Urinary enterolactone is associated with obesity and metabolic alteration in men in the US National Health and Nutrition Examination Survey 2001-10,” The British Journal of Nutrition, vol. 113, pp. 683–690, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Qin, Y. Li, Z. Cai et al., “A metagenome-wide association study of gut microbiota in type 2 diabetes,” Nature, vol. 490, pp. 55–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Moco, F.-P. J. Martin, and S. Rezzi, “Metabolomics view on gut microbiome modulation by polyphenol-rich foods,” Journal of Proteome Research, vol. 11, pp. 4781–4790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Martín-Peláez, J. I. Mosele, N. Pizarro et al., “Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota,” European Journal of Nutrition, vol. 56, pp. 119–131, 2017. View at Publisher · View at Google Scholar · View at Scopus
  93. V. Fogliano, M. L. Corollaro, P. Vitaglione et al., “In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction,” Molecular Nutrition & Food Research, vol. 55, Supplement 1, pp. S44–S55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. X. Tzounis, A. Rodriguez-Mateos, J. Vulevic, G. R. Gibson, C. Kwik-Uribe, and J. P. Spencer, “Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study,” The American Journal of Clinical Nutrition, vol. 93, pp. 62–72, 2011. View at Publisher · View at Google Scholar · View at Scopus